News & Publications

Identifai-Genetics Launches Its First U.S. Clinical Trial,…

Identifai-Genetics, developer of unique AI-based solutions for non-invasive fetal DNA sequencing, announced today that it has launched its first...

Asset Preview Total Pages: 

Decoding DNA To Birth Defects In Unborn…

Israeli startup Identifai Genetics says it can determine whether a baby will be born with any kind of genetic disorder...

Asset Preview Total Pages: 

Identifai-Genetics Closes a Post-Seed Fundraising Round of…

Identifai offers unique, innovative solutions for the non-invasive detection of fetal genetic disorders, at an early stage of the...

Asset Preview Total Pages: 

Identifai-Genetics wins IIA approval for a NIS 9M…

We are delighted to announce that Identifai-Genetics won the approval the Israel Innovation Authority (IIA) for a NIS 9M...

Asset Preview Total Pages: 

Improved noninvasive fetal variant calling using standardized…

The technology of noninvasive prenatal testing (NIPT) enables risk-free detection of genetic conditions in the fetus, by analysis of cell...

Asset Preview Total Pages: 

Bayesian-based noninvasive prenatal diagnosis of single-gene disorders

In the last decade, noninvasive prenatal diagnosis (NIPD) has emerged as an effective procedure for early detection of inherited diseases...

Asset Preview Total Pages: